Alembic Intangible Assets from 2010 to 2024

APLLTD Stock   1,093  51.35  4.93%   
Alembic Pharmaceuticals' Intangible Assets are increasing over the years with stable fluctuation. Intangible Assets are expected to dwindle to 0.00. Intangible Assets is non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value. View All Fundamentals
 
Intangible Assets  
First Reported
2010-12-31
Previous Quarter
0.0
Current Value
0.0
Quarterly Volatility
1.2 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Alembic Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Alembic Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.9 B, Interest Expense of 590 M or Selling And Marketing Expenses of 5.1 B, as well as many indicators such as . Alembic financial statements analysis is a perfect complement when working with Alembic Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement various Alembic Pharmaceuticals Technical models . Check out the analysis of Alembic Pharmaceuticals Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Alembic Stock

Alembic Pharmaceuticals financial ratios help investors to determine whether Alembic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alembic with respect to the benefits of owning Alembic Pharmaceuticals security.